A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis

NCT00876447 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

397

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

BIOLOGICAL: Botulinum Toxin Type A 300U
BIOLOGICAL: Botulinum Toxin Type A 200U

Sponsor

Allergan